Cited 32 time in
A Novel Magnetic Actuation Scheme to Disaggregate Nanoparticles and Enhance Passage across the Blood-Brain Barrier
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Hoshiar, Ali Kafash | - |
| dc.contributor.author | Tuan-Anh Le | - |
| dc.contributor.author | Ul Amin, Faiz | - |
| dc.contributor.author | Kim, Myeong Ok | - |
| dc.contributor.author | Yoon, Jungwon | - |
| dc.date.accessioned | 2022-12-26T17:18:00Z | - |
| dc.date.available | 2022-12-26T17:18:00Z | - |
| dc.date.issued | 2018-01 | - |
| dc.identifier.issn | 2079-4991 | - |
| dc.identifier.uri | https://scholarworks.gnu.ac.kr/handle/sw.gnu/12012 | - |
| dc.description.abstract | The blood-brain barrier (BBB) hinders drug delivery to the brain. Despite various efforts to develop preprogramed actuation schemes for magnetic drug delivery, the unmodeled aggregation phenomenon limits drug delivery performance. This paper proposes a novel scheme with an aggregation model for a feed-forward magnetic actuation design. A simulation platform for aggregated particle delivery is developed and an actuation scheme is proposed to deliver aggregated magnetic nanoparticles (MNPs) using a discontinuous asymmetrical magnetic actuation. The experimental results with a Y-shaped channel indicated the success of the proposed scheme in steering and disaggregation. The delivery performance of the developed scheme was examined using a realistic, three-dimensional (3D) vessel simulation. Furthermore, the proposed scheme enhanced the transport and uptake of MNPs across the BBB in mice. The scheme presented here facilitates the passage of particles across the BBB to the brain using an electromagnetic actuation scheme. | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | MDPI AG | - |
| dc.title | A Novel Magnetic Actuation Scheme to Disaggregate Nanoparticles and Enhance Passage across the Blood-Brain Barrier | - |
| dc.type | Article | - |
| dc.publisher.location | 스위스 | - |
| dc.identifier.doi | 10.3390/nano8010003 | - |
| dc.identifier.scopusid | 2-s2.0-85039904991 | - |
| dc.identifier.wosid | 000424131600003 | - |
| dc.identifier.bibliographicCitation | NANOMATERIALS, v.8, no.1 | - |
| dc.citation.title | NANOMATERIALS | - |
| dc.citation.volume | 8 | - |
| dc.citation.number | 1 | - |
| dc.type.docType | Article | - |
| dc.description.isOpenAccess | Y | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Chemistry | - |
| dc.relation.journalResearchArea | Science & Technology - Other Topics | - |
| dc.relation.journalResearchArea | Materials Science | - |
| dc.relation.journalResearchArea | Physics | - |
| dc.relation.journalWebOfScienceCategory | Chemistry, Multidisciplinary | - |
| dc.relation.journalWebOfScienceCategory | Nanoscience & Nanotechnology | - |
| dc.relation.journalWebOfScienceCategory | Materials Science, Multidisciplinary | - |
| dc.relation.journalWebOfScienceCategory | Physics, Applied | - |
| dc.subject.keywordPlus | GUIDED DRUG-DELIVERY | - |
| dc.subject.keywordPlus | SIMULATION | - |
| dc.subject.keywordPlus | SYSTEM | - |
| dc.subject.keywordPlus | FIELD | - |
| dc.subject.keywordPlus | AGGREGATIONS | - |
| dc.subject.keywordPlus | VESSELS | - |
| dc.subject.keywordPlus | FLOW | - |
| dc.subject.keywordAuthor | asymmetrical discontinuous field function | - |
| dc.subject.keywordAuthor | blood-brain barrier (BBB) | - |
| dc.subject.keywordAuthor | magnetic drug delivery | - |
| dc.subject.keywordAuthor | magnetic nanoparticles | - |
| dc.subject.keywordAuthor | aggregation | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0532
COPYRIGHT 2022 GYEONGSANG NATIONAL UNIVERSITY LIBRARY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
